398 related articles for article (PubMed ID: 14600276)
21. Efficacy of the rePON1 mutant IIG1 to prevent cyclosarin toxicity in vivo and to detoxify structurally different nerve agents in vitro.
Worek F; Seeger T; Goldsmith M; Ashani Y; Leader H; Sussman JS; Tawfik D; Thiermann H; Wille T
Arch Toxicol; 2014 Jun; 88(6):1257-66. PubMed ID: 24477626
[TBL] [Abstract][Full Text] [Related]
22. Protection of red blood cell acetylcholinesterase by oral huperzine A against ex vivo soman exposure: next generation prophylaxis and sequestering of acetylcholinesterase over butyrylcholinesterase.
Haigh JR; Johnston SR; Peppernay A; Mattern PJ; Garcia GE; Doctor BP; Gordon RK; Aisen PS
Chem Biol Interact; 2008 Sep; 175(1-3):380-6. PubMed ID: 18572153
[TBL] [Abstract][Full Text] [Related]
23. [Today's threat of use of organophosphorus compounds].
Sokołowski R; Płusa T
Pol Merkur Lekarski; 2015 Sep; 39(231):176-80. PubMed ID: 26449583
[TBL] [Abstract][Full Text] [Related]
24. Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: a kinetic analysis.
Aurbek N; Thiermann H; Eyer F; Eyer P; Worek F
Toxicology; 2009 May; 259(3):133-9. PubMed ID: 19428953
[TBL] [Abstract][Full Text] [Related]
25. Kinetic constants for the inhibition of eel and rabbit brain acetylcholinesterase by some organophosphates and carbamates of military significance.
Gray PJ; Dawson RM
Toxicol Appl Pharmacol; 1987 Oct; 91(1):140-4. PubMed ID: 3672515
[TBL] [Abstract][Full Text] [Related]
26. Gender difference in the miotic potency of soman vapor in rats.
Dabisch PA; Horsmon MS; Taylor JT; Muse WT; Miller DB; Sommerville DR; Mioduszewski RJ; Thomson S
Cutan Ocul Toxicol; 2008; 27(2):123-33. PubMed ID: 18568898
[TBL] [Abstract][Full Text] [Related]
27. Simulated dermal contamination with capillary samples and field cholinesterase biomonitoring.
Yuknavage KL; Fenske RA; Kalman DA; Keifer MC; Furlong CE
J Toxicol Environ Health; 1997 May; 51(1):35-55. PubMed ID: 9169060
[TBL] [Abstract][Full Text] [Related]
28. Differential mRNA expression of acetylcholinesterase in the central nervous system of rats with acute and chronic exposure of sarin & physostigmine.
Bansal I; Waghmare CK; Anand T; Gupta AK; Bhattacharya BK
J Appl Toxicol; 2009 Jul; 29(5):386-94. PubMed ID: 19283689
[TBL] [Abstract][Full Text] [Related]
29. Equine butyrylcholinesterase protects rats against inhalation exposure to sublethal sarin concentrations.
Bajgar J; Bartosova L; Fusek J; Jun D; Kuca K
Arh Hig Rada Toksikol; 2006 Dec; 57(4):391-5. PubMed ID: 17265678
[TBL] [Abstract][Full Text] [Related]
30. Post-exposure treatment of VX poisoned guinea pigs with the engineered phosphotriesterase mutant C23: a proof-of-concept study.
Worek F; Seeger T; Reiter G; Goldsmith M; Ashani Y; Leader H; Sussman JL; Aggarwal N; Thiermann H; Tawfik DS
Toxicol Lett; 2014 Nov; 231(1):45-54. PubMed ID: 25195526
[TBL] [Abstract][Full Text] [Related]
31. Biochemical effects of low level exposure to soman vapour.
Bajgar J; Sevelová L; Krejcová G; Fusek J; Vachek J; Kassa J; Herink J; de Jong LP; Benschop H
Cent Eur J Public Health; 2004 Mar; 12 Suppl():S4-7. PubMed ID: 15141961
[TBL] [Abstract][Full Text] [Related]
32. Bioscavengers for the protection of humans against organophosphate toxicity.
Doctor BP; Saxena A
Chem Biol Interact; 2005 Dec; 157-158():167-71. PubMed ID: 16293236
[TBL] [Abstract][Full Text] [Related]
33. Structural and kinetic evidence of aging after organophosphate inhibition of human Cathepsin A.
Bouknight KD; Jurkouich KM; Compton JR; Khavrutskii IV; Guelta MA; Harvey SP; Legler PM
Biochem Pharmacol; 2020 Jul; 177():113980. PubMed ID: 32305437
[TBL] [Abstract][Full Text] [Related]
34. Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman.
Gordon RK; Haigh JR; Garcia GE; Feaster SR; Riel MA; Lenz DE; Aisen PS; Doctor BP
Chem Biol Interact; 2005 Dec; 157-158():239-46. PubMed ID: 16256090
[TBL] [Abstract][Full Text] [Related]
35. Effect of metoclopramide and ranitidine on the inhibition of human AChE by VX in vitro.
Bartling A; Thiermann H; Szinicz L; Worek F
J Appl Toxicol; 2005; 25(6):568-71. PubMed ID: 16167316
[TBL] [Abstract][Full Text] [Related]
36. Analysis of inhibition, reactivation and aging kinetics of highly toxic organophosphorus compounds with human and pig acetylcholinesterase.
Aurbek N; Thiermann H; Szinicz L; Eyer P; Worek F
Toxicology; 2006 Jul; 224(1-2):91-9. PubMed ID: 16720069
[TBL] [Abstract][Full Text] [Related]
37. Advantages of the WRAIR whole blood cholinesterase assay: comparative analysis to the micro-Ellman, Test-mate ChE, and Michel (DeltapH) assays.
Haigh JR; Lefkowitz LJ; Capacio BR; Doctor BP; Gordon RK
Chem Biol Interact; 2008 Sep; 175(1-3):417-20. PubMed ID: 18555983
[TBL] [Abstract][Full Text] [Related]
38. Blood and bronchoalveolar lavage fluid acetylcholinesterase levels following microinstillation inhalation exposure to sarin in Guinea pigs.
Che MM; Conti M; Boylan M; Sciuto AM; Gordon RK; Nambiar MP
Inhal Toxicol; 2008 Jul; 20(9):821-8. PubMed ID: 18645722
[TBL] [Abstract][Full Text] [Related]
39. Changes of cholinesterase activities in the rat blood and brain after sarin intoxication pretreated with butyrylcholinesterase.
Bajgar J; Bartosova L; Kuca K; Jun D; Fusek J
Drug Chem Toxicol; 2007; 30(4):351-9. PubMed ID: 17934924
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of reactivation test in anaesthetized dogs with experimental intoxication with nerve agents.
Bajgar J; Fusek J; Bartosova L; Jun D; Kuca K
J Appl Toxicol; 2006; 26(5):439-43. PubMed ID: 16915560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
